share_log

賽生藥業:(1) SILVER PEGASUS INVESTMENT LIMITED建議(根據公司法第86條)以協議安排方式將賽生藥業控股有限公司私有化;(2) 建議撤銷賽生藥業控股有限公司的上市地位;(3) 有關存續安排的特定交易;(4) 成立獨立董事委員會;(5) 委任獨立財務顧問;及 (6) 恢復股份買賣

SCICLONE PHARMA: (1) PROPOSAL FOR THE PRIVATISATION OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED BY SILVER PEGASUS INVESTMENT LIMITED BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES ACT); (2) PROPOSED WITHDRAWAL OF LISTING OF SCICLON

香港交易所 ·  Mar 28 04:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more